Steven Masson
Steven Masson
Institute of Cellular Medicine, Newcastle University
Verified email at nuth.nhs.uk
Title
Cited by
Cited by
Year
Prednisolone or pentoxifylline for alcoholic hepatitis
MR Thursz, P Richardson, M Allison, A Austin, M Bowers, CP Day, ...
New England Journal of Medicine 372 (17), 1619-1628, 2015
4902015
Multigenerational epigenetic adaptation of the hepatic wound-healing response
M Zeybel, T Hardy, YK Wong, JC Mathers, CR Fox, A Gackowska, ...
Nature medicine 18 (9), 1369-1377, 2012
2502012
Potential of hematopoietic stem cell therapy in hepatology: a critical review
S Masson, DJ Harrison, JN Plevris, PN Newsome
Stem cells 22 (6), 897-907, 2004
1252004
Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease
T Hardy, M Zeybel, CP Day, C Dipper, S Masson, S McPherson, ...
Gut 66 (7), 1321-1328, 2017
1102017
A TLR2/S100A9/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse
A Moles, L Murphy, CL Wilson, JB Chakraborty, C Fox, EJ Park, J Mann, ...
Journal of hepatology 60 (4), 782-791, 2014
972014
Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease
M Zeybel, T Hardy, SM Robinson, C Fox, QM Anstee, T Ness, S Masson, ...
Clinical epigenetics 7 (1), 1-11, 2015
912015
In patients with severe alcoholic hepatitis, prednisolone increases susceptibility to infection and infection-related mortality, and Is associated with high circulating levels …
N Vergis, SR Atkinson, S Knapp, J Maurice, M Allison, A Austin, ...
Gastroenterology 152 (5), 1068-1077. e4, 2017
852017
Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion: a decade of experience
S Masson, HA Mardini, JD Rose, CO Record
QJM: An International Journal of Medicine 101 (6), 493-501, 2008
822008
Steroids or pentoxifylline for alcoholic hepatitis (STOPAH): study protocol for a randomised controlled trial
E Forrest, J Mellor, L Stanton, M Bowers, P Ryder, A Austin, C Day, ...
Trials 14 (1), 262, 2013
682013
The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease
M Boyle, S Masson, QM Anstee
Journal of hepatology 68 (2), 251-267, 2018
572018
Application of prognostic scores in the STOPAH trial: Discriminant function is no longer the optimal scoring system in alcoholic hepatitis
EH Forrest, SR Atkinson, P Richardson, S Masson, S Ryder, MR Thursz, ...
Journal of hepatology 68 (3), 511-518, 2018
442018
White cell count and platelet count associate with histological alcoholic hepatitis in jaundiced harmful drinkers
T Hardy, C Wells, S Kendrick, M Hudson, CP Day, AD Burt, S Masson, ...
BMC gastroenterology 13 (1), 55, 2013
362013
The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury
L Barbier-Torres, P Iruzubieta, D Fernández-Ramos, TC Delgado, ...
Nature communications 8 (1), 1-11, 2017
352017
Cholestasis secondary to anabolic steroid use in young men
AM Elsharkawy, S McPherson, S Masson, AD Burt, RT Dawson, ...
Bmj 344, e468, 2012
352012
Is anaemia relevant in the referral and diagnosis of colorectal cancer?
S Masson, DJ Chinn, MA Tabaqchali, G Waddup, AD Dwarakanath
Colorectal Disease 9 (8), 736-739, 2007
312007
Serum from patients with fulminant hepatic failure causes hepatocyte detachment and apoptosis by a β1‐integrin pathway
PN Newsome, J Tsiaoussis, S Masson, R Buttery, C Livingston, I Ansell, ...
Hepatology 40 (3), 636-645, 2004
282004
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study
GJ Webb, T Marjot, JA Cook, C Aloman, MJ Armstrong, EJ Brenner, ...
The Lancet Gastroenterology & Hepatology 5 (11), 1008-1016, 2020
272020
Brief Report: Genetics of Alcoholic Cirrhosis—G enom ALC Multinational Study
JB Whitfield, K Rahman, PS Haber, CP Day, S Masson, AK Daly, ...
Alcoholism: Clinical and Experimental Research 39 (5), 836-842, 2015
262015
An ‘alcohol contract’has no significant effect on return to drinking after liver transplantation for alcoholic liver disease
S Masson, B Marrow, S Kendrick, AM Elsharkawy, S Latimer, M Hudson
Transplant International 27 (5), 475-481, 2014
262014
Clinical but not histological factors predict long‐term prognosis in patients with histologically advanced non‐decompensated alcoholic liver disease
S Masson, I Emmerson, E Henderson, EH Fletcher, AD Burt, CP Day, ...
Liver International 34 (2), 235-242, 2014
262014
The system can't perform the operation now. Try again later.
Articles 1–20